OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial launches for Tough-to-Treat ovarian cancer
Disease control Not yet recruitingThis large, late-stage study aims to find out if a new drug called GSK5733584 works better than standard chemotherapy for women with ovarian cancer that has become resistant to platinum-based drugs. It will enroll about 450 participants to directly compare how long the cancer is …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Spray-On chemo tested for Tough-to-Treat ovarian cancer
Disease control Not yet recruitingThis early-stage study is testing a new way to deliver chemotherapy directly into the abdomen for women with recurrent ovarian cancer that has stopped responding to standard platinum drugs. Doctors will spray a chemotherapy drug (paclitaxel) as a fine mist during a minimally inva…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers
Disease control Not yet recruitingThis trial is testing if two already-approved cancer drugs, dabrafenib and trametinib, can help patients with rare cancers or common cancers that have a rare, specific genetic change called a BRAF V600 mutation. The drugs are already used for some cancers like melanoma, but resea…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC